SHARE

Each week, DCN will curate a rundown of startup, tech, and innovation news in the cannabis industry for its new series, DCN Micro News.

February 25th, 2019

Cannex Signs Agreement To Acquire California Based Pure Ratios

Cannex Capital Holdings Inc. (CSE: CNNX) (OTCQX: CNXXF) (“Cannex” or the “Company”) is pleased to announce that it has signed a binding letter agreement (the “Agreement”) to acquire 100% of San Diego, California based Pure Ratios Holdings, Inc. (“Pure Ratios”), (the “Transaction”) in a cash and stock transaction.

Original Press Release, Click Here.

SOL Global Announces Formation of International Hemp Company Heavenly Rx

SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) is pleased to announce the formation of a new international hemp-focused subsidiary, Heavenly Rx Ltd. (“Heavenly Rx”).

Heavenly Rx intends to hold controlling ownership interests in various industry-leading assets in the hemp/CBD and THC-free cannabinoid wellness space, with an initial focus on hemp cultivation, processing and the manufacturing of a diverse range of traditional CBD products including oils, tinctures, balms, and vape-ready products.

Original Press Release, Click Here.

February 26th, 2019

4Front Strengthens Platform with Acquisitions in Massachusetts and Arizona

4Front Holdings, LLC (“4Front”), a leading retail and brand development company in the U.S. cannabis sector, has closed two recent acquisitions that expand its national reach and position it well in Massachusetts’ nascent adult-use market and in Arizona, where voters have a good chance of legalizing cannabis for adult use by ballot initiative in 2020.

In Massachusetts, 4Front has acquired Healthy Pharms, Inc. (“Healthy Pharms”), a vertically integrated cannabis company that operates dispensaries in Georgetown and Cambridge’s Harvard Square. The Georgetown property is also home to a cultivation and processing facility that has the space for significant expansion.

In Arizona, 4Front has acquired PHX Interactive, LLC, which manages vertically integrated license holder Greens Goddess Products, Inc. (“Greens Goddess”). Greens Goddess currently owns the Herb’N dispensary in northern Phoenix. Along with the existing dispensary, the license allows for the operation of a cultivation and processing facility, but Greens Goddess has not developed that capacity yet.

Original Press Release, Click Here.

Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership

Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has agreed to terms to acquire a 51% ownership interest in Gaia Pharm Lda., a license applicant in Portugal, to establish a local facility to produce medical cannabis and derivative products. The company will be renamed “Aurora Portugal Lda”.

On February 21, 2019, Gaia Pharm Lda. received approval of its application to construct an EU GMP compliant cannabis cultivation facility from INFARMED, a division of the Portuguese Health Ministry, which is responsible for the evaluation, authorization, regulation and control of human medicines as well as health products for the protection of public health.

Original Press Release, Click Here.

February 27th, 2019

Curaleaf To Establish Vertically Integrated Operations in California Through Strategic Acquisition

Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced it has signed a definitive agreement to acquire Eureka Investment Partners, LLC (“Eureka”). Based in Monterey County, California, Eureka operates a cultivation facility in the Salinas Valley and is developing three dispensaries across the state.

The addition of Eureka’s cultivation platform will provide Curaleaf access to California’s wholesale market through an existing 110,000 sq. ft. greenhouse facility in Salinas, California, with the potential to expand up to 270,000 sq. ft. that could generate over 50,000 pounds of dry flower per year at full scale.

Original Press Release, Click Here.

February 28th, 2019

CannaPharmaRx Announces the Acquisition of a Minority Interest in GN Ventures, a Canadian Cannabis Producer, and the Appointment of Dominic Colvin as CEO and Chairman of the Board

CannaPharmaRx, Inc. (OTC Pink Sheets: “CPMD”) announced today it has completed the acquisition of a minority interest in GN Ventures, LTD., (“GNC”), an Alberta corporation, engaged in the development of Canadian cannabis cultivation facilities. Under the terms of the stock purchase agreement, the Company acquired approximately eighteen (18%) percent of the issued and outstanding securities of GNC for total consideration of 7,998,963 shares of CPMD common stock. Additionally, the Company acquired warrants exercisable to purchase an additional 2,500,000 shares of GN at an exercise price of CAD$1.00 per share.

Original Press Release, Click Here.

March 1st, 2019

Jacana Completes First Ever Global Export of Jamaican Cannabis

Jacana today announces the launch of a new kind of medical company that harnesses the power of nature to produce certified medical cannabis, providing natural relief for chronic pain and suffering.

Chronic pain affects 1.5 billion people worldwide, with more than 100 million people suffering in the US alone.1

Jacana has completed the first-ever international export of Jamaican medical cannabis flower, securing multiple international licenses and permits to date. The deal also saw Jacana play a central role in shaping the international regulatory process.

Original Press Release, Click Here.

Do you have an upcoming press release or announcement you want to share with DCN and our readers? Find us on twitter, @_dcnetwork_ or email submitthis@directcannabisnetwork.com.


Warning: A non-numeric value encountered in /home/content/p3pnexwpnas13_data01/53/42588953/html/wp-content/themes/Newsmag/includes/wp_booster/td_block.php on line 353

This site uses Akismet to reduce spam. Learn how your comment data is processed.